Inbar L, Lapidot A
Isotope Department, Weizmann Institute, Rehovot, Israel.
J Bacteriol. 1988 Sep;170(9):4055-64. doi: 10.1128/jb.170.9.4055-4064.1988.
Recent studies have suggested that the onset of synthesis of actinomycin D in Streptomyces parvulus is due to a release from L-glutamate catabolic repression. In the present investigation we showed that S. parvulus has the capacity to maintain high levels of intracellular glutamate during the synthesis of actinomycin D. The results seem contradictory, since actinomycin D synthesis cannot start before a release from L-glutamate catabolic repression, but a relatively high intracellular pool of glutamate is needed for the synthesis of actinomycin D. Utilizing different labeled precursors, D-[U-13C]fructose and 13C- and 15N-labeled L-glutamate, and nuclear magnetic resonance techniques, we showed that carbon atoms of an intracellular glutamate pool of S. parvulus were not derived biosynthetically from the culture medium glutamate source but rather from D-fructose catabolism. A new intracellular pyrimidine derivative whose nitrogen and carbon skeletons were derived from exogenous L-glutamate was obtained as the main glutamate metabolite. Another new pyrimidine derivative that had a significantly reduced intracellular mobility and that was derived from D-fructose catabolism was identified in the cell extracts of S. parvulus during actinomycin D synthesis. These pyrimidine derivatives may serve as a nitrogen store for actinomycin D synthesis. In the present study, the N-trimethyl group of a choline derivative was observed by 13C nuclear magnetic resonance spectroscopy in growing S. parvulus cells. The choline group, as well as the N-methyl groups of sarcosine, N-methyl-valine, and the methyl groups of an actinomycin D chromophore, arose from D-fructose catabolism. The 13C enrichments found in the peptide moieties of actinomycin D were in accordance with a mechanism of actinomycin D synthesis from L-glutamate and D-fructose.
最近的研究表明,小链霉菌中放线菌素D合成的起始是由于从L-谷氨酸分解代谢阻遏中释放出来。在本研究中,我们表明小链霉菌在放线菌素D合成过程中具有维持细胞内谷氨酸高水平的能力。结果似乎相互矛盾,因为放线菌素D合成在从L-谷氨酸分解代谢阻遏中释放之前无法开始,但放线菌素D合成需要相对较高的细胞内谷氨酸池。利用不同的标记前体、D-[U-¹³C]果糖以及¹³C和¹⁵N标记的L-谷氨酸,以及核磁共振技术,我们表明小链霉菌细胞内谷氨酸池的碳原子并非生物合成自培养基中的谷氨酸源,而是来自D-果糖分解代谢。获得了一种新的细胞内嘧啶衍生物,其氮和碳骨架源自外源L-谷氨酸,是主要的谷氨酸代谢产物。在放线菌素D合成过程中,在小链霉菌的细胞提取物中鉴定出另一种新的嘧啶衍生物,其细胞内迁移率显著降低,源自D-果糖分解代谢。这些嘧啶衍生物可能作为放线菌素D合成的氮储备。在本研究中,通过¹³C核磁共振光谱在生长的小链霉菌细胞中观察到了胆碱衍生物的N-三甲基基团。胆碱基团以及肌氨酸、N-甲基缬氨酸的N-甲基基团和放线菌素D发色团的甲基基团均源自D-果糖分解代谢。放线菌素D肽部分中发现的¹³C富集与由L-谷氨酸和D-果糖合成放线菌素D的机制一致。